Skip Navigation
Text Size: A  A  A
Genetic and Rare Diseases Information Center (GARD)



Acute myelomonocytic leukemia
ORDR lists rare diseases for information purposes only and does not guarantee that a condition is rare. Read more
The links on this page may take you to sites outside of the NIH. (See Disclaimer for details.)


Acute myelomonocytic leukemia (AMML) is a cancer that typically develops in the bone marrow and blood of older individuals.  AMML is one type of acute myeloid leukemia, a group of blood cancers that occur when the amount of white blood cells increases rapidly.  Symptoms of AMML often include fatigue (due to anemia) or easy bruising or bleeding (due to thrombocytopenia).  The cause of AMML is currently unknown.  Treatment typically consists of chemotherapy.[1]


References
  1. American Cancer Society. Detailed Guide. Leukemia - Acute Myeloid (Myelogenous). January 2013 Available at: http://www.cancer.org/cancer/leukemia-acutemyeloidaml/detailedguide/index. Accessed February 12, 2013.
click to take you to contact us form

Questions & Answers (Found 1 Question)
A list of questions from the public on rare and/or genetic diseases that have been answered by the Genetic and Rare Disease Information Center. Click on each question to find the answer.
For more information about Acute myelomonocytic leukemia click on the boxes below:
More Detailed Information Organizations Services Scientific Conferences Clinical Trials & Research